Medical Care
Global Biomarkers Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jul 08, 25
- ID: 349812
- Pages: 117
- Figures: 125
- Views: 12
In 2024, the global market size of Biomarkers was estimated to be worth US$ 82490 million and is forecast to reach approximately US$ 211410 million by 2031 with a CAGR of 14.6% during the forecast period 2025-2031.
In biological system, it means to calculate the whole number by marking part of individuals.
North America is the largest consumption place, with a consumption market share nearly 32% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 22.5%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Biomarkers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biomarkers.
The Biomarkers market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biomarkers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biomarkers companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Merck
Bio-Rad Laboratories
QIAGEN
Roche
Danaher Corporation
Siemens Healthcare
Abbott
Agilent Technologies
Segment by Type
Sepsis Biomarkers
Antibiotic Resistance Biomarkers
Traumatic Brain Injury (TBI) Testing Biomarkers
Stroke Testing Biomarkers
Antibiotic Stewardship Biomarkers
Other
Segment by Application
Diagnostics
Drug Discovery
Personalized Medicine
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Biomarkers in global and regional level.
Chapter 3: Detailed analysis of Biomarkers company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biomarkers revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
In biological system, it means to calculate the whole number by marking part of individuals.
North America is the largest consumption place, with a consumption market share nearly 32% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 22.5%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Biomarkers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biomarkers.
The Biomarkers market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biomarkers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biomarkers companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Merck
Bio-Rad Laboratories
QIAGEN
Roche
Danaher Corporation
Siemens Healthcare
Abbott
Agilent Technologies
Segment by Type
Sepsis Biomarkers
Antibiotic Resistance Biomarkers
Traumatic Brain Injury (TBI) Testing Biomarkers
Stroke Testing Biomarkers
Antibiotic Stewardship Biomarkers
Other
Segment by Application
Diagnostics
Drug Discovery
Personalized Medicine
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Biomarkers in global and regional level.
Chapter 3: Detailed analysis of Biomarkers company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biomarkers revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
1 Study Coverage
1.1 Biomarkers Product Introduction
1.2 Market by Type
1.2.1 Global Biomarkers Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Sepsis Biomarkers
1.2.3 Antibiotic Resistance Biomarkers
1.2.4 Traumatic Brain Injury (TBI) Testing Biomarkers
1.2.5 Stroke Testing Biomarkers
1.2.6 Antibiotic Stewardship Biomarkers
1.2.7 Other
1.3 Market by Application
1.3.1 Global Biomarkers Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Diagnostics
1.3.3 Drug Discovery
1.3.4 Personalized Medicine
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Biomarkers Market Size Estimates and Forecasts
2.2 Biomarkers Market Size by Region: 2024 Versus 2031
2.2.1 Global Biomarkers Revenue by Region: 2020-2025
2.2.2 Global Biomarkers Revenue Forecast by Region (2026-2031)
2.2.3 Global Biomarkers Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Biomarkers Revenue by Type (2020-2031)
3.1.2 Global Biomarkers Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Biomarkers Revenue by Application (2020-2031)
3.2.2 Global Biomarkers Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Sepsis Biomarkers of Biomarkers Revenue Market Share by Application
3.3.2 Antibiotic Resistance Biomarkers of Biomarkers Revenue Market Share by Application
3.3.3 Traumatic Brain Injury (TBI) Testing Biomarkers of Biomarkers Revenue Market Share by Application
3.3.4 Stroke Testing Biomarkers of Biomarkers Revenue Market Share by Application
3.3.5 Antibiotic Stewardship Biomarkers of Biomarkers Revenue Market Share by Application
3.3.6 Other of Biomarkers Revenue Market Share by Application
4 Global Biomarkers by Company
4.1 Global Biomarkers Revenue by Company (2020-2025)
4.2 Global Biomarkers Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Biomarkers Companies around the World: Ranking by Revenue
4.3.2 Global Biomarkers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Biomarkers Companies Headquarters & Product Type
4.4.1 Global Biomarkers Companies Headquarters
4.4.2 Date of International Companies Enter into Biomarkers Market
4.4.3 Global Biomarkers Companies Product & Service
4.4.4 Sepsis Biomarkers Revenue Market Share of Biomarkers by Company
4.4.5 Antibiotic Resistance Biomarkers Revenue Market Share of Biomarkers by Company
4.4.6 Traumatic Brain Injury (TBI) Testing Biomarkers Revenue Market Share of Biomarkers by Company
4.4.7 Stroke Testing Biomarkers Revenue Market Share of Biomarkers by Company
4.4.8 Antibiotic Stewardship Biomarkers Revenue Market Share of Biomarkers by Company
4.4.9 Other Revenue Market Share of Biomarkers by Company
4.5 Global Biomarkers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Thermo Fisher Scientific
5.1.1 Thermo Fisher Scientific Corporation Information
5.1.2 Thermo Fisher Scientific Description, Business Overview
5.1.3 Thermo Fisher Scientific Biomarkers Products Offered
5.1.4 Thermo Fisher Scientific Biomarkers Revenue and Gross Margin (2020-2025)
5.1.5 Thermo Fisher Scientific Biomarkers Revenue by Product in 2024
5.1.6 Thermo Fisher Scientific Biomarkers Revenue by Application in 2024
5.1.7 Thermo Fisher Scientific Biomarkers Revenue by Geographic Area in 2024
5.1.8 Thermo Fisher Scientific Recent Developments
5.2 Merck
5.2.1 Merck Corporation Information
5.2.2 Merck Description, Business Overview
5.2.3 Merck Biomarkers Products Offered
5.2.4 Merck Biomarkers Revenue and Gross Margin (2020-2025)
5.2.5 Merck Biomarkers Revenue by Product in 2024
5.2.6 Merck Biomarkers Revenue by Application in 2024
5.2.7 Merck Biomarkers Revenue by Geographic Area in 2024
5.2.8 Merck Recent Developments
5.3 Bio-Rad Laboratories
5.3.1 Bio-Rad Laboratories Corporation Information
5.3.2 Bio-Rad Laboratories Description, Business Overview
5.3.3 Bio-Rad Laboratories Biomarkers Products Offered
5.3.4 Bio-Rad Laboratories Biomarkers Revenue and Gross Margin (2020-2025)
5.3.5 Bio-Rad Laboratories Biomarkers Revenue by Product in 2024
5.3.6 Bio-Rad Laboratories Biomarkers Revenue by Application in 2024
5.3.7 Bio-Rad Laboratories Biomarkers Revenue by Geographic Area in 2024
5.3.8 Bio-Rad Laboratories Recent Developments
5.4 QIAGEN
5.4.1 QIAGEN Corporation Information
5.4.2 QIAGEN Description, Business Overview
5.4.3 QIAGEN Biomarkers Products Offered
5.4.4 QIAGEN Biomarkers Revenue and Gross Margin (2020-2025)
5.4.5 QIAGEN Biomarkers Revenue by Product in 2024
5.4.6 QIAGEN Biomarkers Revenue by Application in 2024
5.4.7 QIAGEN Biomarkers Revenue by Geographic Area in 2024
5.4.8 QIAGEN Recent Developments
5.5 Roche
5.5.1 Roche Corporation Information
5.5.2 Roche Description, Business Overview
5.5.3 Roche Biomarkers Products Offered
5.5.4 Roche Biomarkers Revenue and Gross Margin (2020-2025)
5.5.5 Roche Biomarkers Revenue by Product in 2024
5.5.6 Roche Biomarkers Revenue by Application in 2024
5.5.7 Roche Biomarkers Revenue by Geographic Area in 2024
5.5.8 Roche Recent Developments
5.6 Danaher Corporation
5.6.1 Danaher Corporation Corporation Information
5.6.2 Danaher Corporation Description, Business Overview
5.6.3 Danaher Corporation Biomarkers Products Offered
5.6.4 Danaher Corporation Biomarkers Revenue and Gross Margin (2020-2025)
5.6.5 Danaher Corporation Biomarkers Revenue by Product in 2024
5.6.6 Danaher Corporation Biomarkers Revenue by Application in 2024
5.6.7 Danaher Corporation Biomarkers Revenue by Geographic Area in 2024
5.6.8 Danaher Corporation Recent Developments
5.7 Siemens Healthcare
5.7.1 Siemens Healthcare Corporation Information
5.7.2 Siemens Healthcare Description, Business Overview
5.7.3 Siemens Healthcare Biomarkers Products Offered
5.7.4 Siemens Healthcare Biomarkers Revenue and Gross Margin (2020-2025)
5.7.5 Siemens Healthcare Biomarkers Revenue by Product in 2024
5.7.6 Siemens Healthcare Biomarkers Revenue by Application in 2024
5.7.7 Siemens Healthcare Biomarkers Revenue by Geographic Area in 2024
5.7.8 Siemens Healthcare Recent Developments
5.8 Abbott
5.8.1 Abbott Corporation Information
5.8.2 Abbott Description, Business Overview
5.8.3 Abbott Biomarkers Products Offered
5.8.4 Abbott Biomarkers Revenue and Gross Margin (2020-2025)
5.8.5 Abbott Biomarkers Revenue by Product in 2024
5.8.6 Abbott Biomarkers Revenue by Application in 2024
5.8.7 Abbott Biomarkers Revenue by Geographic Area in 2024
5.8.8 Abbott Recent Developments
5.9 Agilent Technologies
5.9.1 Agilent Technologies Corporation Information
5.9.2 Agilent Technologies Description, Business Overview
5.9.3 Agilent Technologies Biomarkers Products Offered
5.9.4 Agilent Technologies Biomarkers Revenue and Gross Margin (2020-2025)
5.9.5 Agilent Technologies Biomarkers Revenue by Product in 2024
5.9.6 Agilent Technologies Biomarkers Revenue by Application in 2024
5.9.7 Agilent Technologies Biomarkers Revenue by Geographic Area in 2024
5.9.8 Agilent Technologies Recent Developments
6 North America
6.1 North America Biomarkers Market Size YoY Growth 2020-2031
6.2 North America Biomarkers Market Facts & Figures by Country (2020-2031)
6.3 North America Biomarkers Revenue by Type (2020-2025)
6.4 North America Biomarkers Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Biomarkers Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Biomarkers Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Biomarkers Revenue by Type (2020-2025)
7.4 Asia-Pacific Biomarkers Revenue by Application (2020-2025)
8 Europe
8.1 Europe Biomarkers Market Size YoY Growth 2020-2031
8.2 Europe Biomarkers Market Facts & Figures by Country (2020-2031)
8.3 Europe Biomarkers Revenue by Type (2020-2025)
8.4 Europe Biomarkers Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Biomarkers Market Size YoY Growth 2020-2031
9.2 Latin America Biomarkers Market Facts & Figures by Country (2020-2031)
9.3 Latin America Biomarkers Revenue by Type (2020-2025)
9.4 Latin America Biomarkers Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Biomarkers Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Biomarkers Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Biomarkers Revenue by Type (2020-2025)
10.4 Middle East and Africa Biomarkers Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Biomarkers Supply Chain Analysis
11.2 Biomarkers Key Raw Materials and Upstream Suppliers
11.3 Biomarkers Clients Analysis
11.4 Biomarkers Sales Channel and Sales Model Analysis
11.4.1 Biomarkers Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Biomarkers Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Biomarkers Distributors
12 Biomarkers Market Dynamics
12.1 Biomarkers Industry Trends
12.2 Biomarkers Market Drivers
12.3 Biomarkers Market Challenges
12.4 Biomarkers Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Biomarkers Product Introduction
1.2 Market by Type
1.2.1 Global Biomarkers Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Sepsis Biomarkers
1.2.3 Antibiotic Resistance Biomarkers
1.2.4 Traumatic Brain Injury (TBI) Testing Biomarkers
1.2.5 Stroke Testing Biomarkers
1.2.6 Antibiotic Stewardship Biomarkers
1.2.7 Other
1.3 Market by Application
1.3.1 Global Biomarkers Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Diagnostics
1.3.3 Drug Discovery
1.3.4 Personalized Medicine
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Biomarkers Market Size Estimates and Forecasts
2.2 Biomarkers Market Size by Region: 2024 Versus 2031
2.2.1 Global Biomarkers Revenue by Region: 2020-2025
2.2.2 Global Biomarkers Revenue Forecast by Region (2026-2031)
2.2.3 Global Biomarkers Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Biomarkers Revenue by Type (2020-2031)
3.1.2 Global Biomarkers Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Biomarkers Revenue by Application (2020-2031)
3.2.2 Global Biomarkers Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Sepsis Biomarkers of Biomarkers Revenue Market Share by Application
3.3.2 Antibiotic Resistance Biomarkers of Biomarkers Revenue Market Share by Application
3.3.3 Traumatic Brain Injury (TBI) Testing Biomarkers of Biomarkers Revenue Market Share by Application
3.3.4 Stroke Testing Biomarkers of Biomarkers Revenue Market Share by Application
3.3.5 Antibiotic Stewardship Biomarkers of Biomarkers Revenue Market Share by Application
3.3.6 Other of Biomarkers Revenue Market Share by Application
4 Global Biomarkers by Company
4.1 Global Biomarkers Revenue by Company (2020-2025)
4.2 Global Biomarkers Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Biomarkers Companies around the World: Ranking by Revenue
4.3.2 Global Biomarkers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Biomarkers Companies Headquarters & Product Type
4.4.1 Global Biomarkers Companies Headquarters
4.4.2 Date of International Companies Enter into Biomarkers Market
4.4.3 Global Biomarkers Companies Product & Service
4.4.4 Sepsis Biomarkers Revenue Market Share of Biomarkers by Company
4.4.5 Antibiotic Resistance Biomarkers Revenue Market Share of Biomarkers by Company
4.4.6 Traumatic Brain Injury (TBI) Testing Biomarkers Revenue Market Share of Biomarkers by Company
4.4.7 Stroke Testing Biomarkers Revenue Market Share of Biomarkers by Company
4.4.8 Antibiotic Stewardship Biomarkers Revenue Market Share of Biomarkers by Company
4.4.9 Other Revenue Market Share of Biomarkers by Company
4.5 Global Biomarkers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Thermo Fisher Scientific
5.1.1 Thermo Fisher Scientific Corporation Information
5.1.2 Thermo Fisher Scientific Description, Business Overview
5.1.3 Thermo Fisher Scientific Biomarkers Products Offered
5.1.4 Thermo Fisher Scientific Biomarkers Revenue and Gross Margin (2020-2025)
5.1.5 Thermo Fisher Scientific Biomarkers Revenue by Product in 2024
5.1.6 Thermo Fisher Scientific Biomarkers Revenue by Application in 2024
5.1.7 Thermo Fisher Scientific Biomarkers Revenue by Geographic Area in 2024
5.1.8 Thermo Fisher Scientific Recent Developments
5.2 Merck
5.2.1 Merck Corporation Information
5.2.2 Merck Description, Business Overview
5.2.3 Merck Biomarkers Products Offered
5.2.4 Merck Biomarkers Revenue and Gross Margin (2020-2025)
5.2.5 Merck Biomarkers Revenue by Product in 2024
5.2.6 Merck Biomarkers Revenue by Application in 2024
5.2.7 Merck Biomarkers Revenue by Geographic Area in 2024
5.2.8 Merck Recent Developments
5.3 Bio-Rad Laboratories
5.3.1 Bio-Rad Laboratories Corporation Information
5.3.2 Bio-Rad Laboratories Description, Business Overview
5.3.3 Bio-Rad Laboratories Biomarkers Products Offered
5.3.4 Bio-Rad Laboratories Biomarkers Revenue and Gross Margin (2020-2025)
5.3.5 Bio-Rad Laboratories Biomarkers Revenue by Product in 2024
5.3.6 Bio-Rad Laboratories Biomarkers Revenue by Application in 2024
5.3.7 Bio-Rad Laboratories Biomarkers Revenue by Geographic Area in 2024
5.3.8 Bio-Rad Laboratories Recent Developments
5.4 QIAGEN
5.4.1 QIAGEN Corporation Information
5.4.2 QIAGEN Description, Business Overview
5.4.3 QIAGEN Biomarkers Products Offered
5.4.4 QIAGEN Biomarkers Revenue and Gross Margin (2020-2025)
5.4.5 QIAGEN Biomarkers Revenue by Product in 2024
5.4.6 QIAGEN Biomarkers Revenue by Application in 2024
5.4.7 QIAGEN Biomarkers Revenue by Geographic Area in 2024
5.4.8 QIAGEN Recent Developments
5.5 Roche
5.5.1 Roche Corporation Information
5.5.2 Roche Description, Business Overview
5.5.3 Roche Biomarkers Products Offered
5.5.4 Roche Biomarkers Revenue and Gross Margin (2020-2025)
5.5.5 Roche Biomarkers Revenue by Product in 2024
5.5.6 Roche Biomarkers Revenue by Application in 2024
5.5.7 Roche Biomarkers Revenue by Geographic Area in 2024
5.5.8 Roche Recent Developments
5.6 Danaher Corporation
5.6.1 Danaher Corporation Corporation Information
5.6.2 Danaher Corporation Description, Business Overview
5.6.3 Danaher Corporation Biomarkers Products Offered
5.6.4 Danaher Corporation Biomarkers Revenue and Gross Margin (2020-2025)
5.6.5 Danaher Corporation Biomarkers Revenue by Product in 2024
5.6.6 Danaher Corporation Biomarkers Revenue by Application in 2024
5.6.7 Danaher Corporation Biomarkers Revenue by Geographic Area in 2024
5.6.8 Danaher Corporation Recent Developments
5.7 Siemens Healthcare
5.7.1 Siemens Healthcare Corporation Information
5.7.2 Siemens Healthcare Description, Business Overview
5.7.3 Siemens Healthcare Biomarkers Products Offered
5.7.4 Siemens Healthcare Biomarkers Revenue and Gross Margin (2020-2025)
5.7.5 Siemens Healthcare Biomarkers Revenue by Product in 2024
5.7.6 Siemens Healthcare Biomarkers Revenue by Application in 2024
5.7.7 Siemens Healthcare Biomarkers Revenue by Geographic Area in 2024
5.7.8 Siemens Healthcare Recent Developments
5.8 Abbott
5.8.1 Abbott Corporation Information
5.8.2 Abbott Description, Business Overview
5.8.3 Abbott Biomarkers Products Offered
5.8.4 Abbott Biomarkers Revenue and Gross Margin (2020-2025)
5.8.5 Abbott Biomarkers Revenue by Product in 2024
5.8.6 Abbott Biomarkers Revenue by Application in 2024
5.8.7 Abbott Biomarkers Revenue by Geographic Area in 2024
5.8.8 Abbott Recent Developments
5.9 Agilent Technologies
5.9.1 Agilent Technologies Corporation Information
5.9.2 Agilent Technologies Description, Business Overview
5.9.3 Agilent Technologies Biomarkers Products Offered
5.9.4 Agilent Technologies Biomarkers Revenue and Gross Margin (2020-2025)
5.9.5 Agilent Technologies Biomarkers Revenue by Product in 2024
5.9.6 Agilent Technologies Biomarkers Revenue by Application in 2024
5.9.7 Agilent Technologies Biomarkers Revenue by Geographic Area in 2024
5.9.8 Agilent Technologies Recent Developments
6 North America
6.1 North America Biomarkers Market Size YoY Growth 2020-2031
6.2 North America Biomarkers Market Facts & Figures by Country (2020-2031)
6.3 North America Biomarkers Revenue by Type (2020-2025)
6.4 North America Biomarkers Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Biomarkers Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Biomarkers Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Biomarkers Revenue by Type (2020-2025)
7.4 Asia-Pacific Biomarkers Revenue by Application (2020-2025)
8 Europe
8.1 Europe Biomarkers Market Size YoY Growth 2020-2031
8.2 Europe Biomarkers Market Facts & Figures by Country (2020-2031)
8.3 Europe Biomarkers Revenue by Type (2020-2025)
8.4 Europe Biomarkers Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Biomarkers Market Size YoY Growth 2020-2031
9.2 Latin America Biomarkers Market Facts & Figures by Country (2020-2031)
9.3 Latin America Biomarkers Revenue by Type (2020-2025)
9.4 Latin America Biomarkers Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Biomarkers Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Biomarkers Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Biomarkers Revenue by Type (2020-2025)
10.4 Middle East and Africa Biomarkers Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Biomarkers Supply Chain Analysis
11.2 Biomarkers Key Raw Materials and Upstream Suppliers
11.3 Biomarkers Clients Analysis
11.4 Biomarkers Sales Channel and Sales Model Analysis
11.4.1 Biomarkers Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Biomarkers Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Biomarkers Distributors
12 Biomarkers Market Dynamics
12.1 Biomarkers Industry Trends
12.2 Biomarkers Market Drivers
12.3 Biomarkers Market Challenges
12.4 Biomarkers Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Biomarkers Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Biomarkers Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Biomarkers Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Biomarkers Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Biomarkers Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Biomarkers Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Biomarkers Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Biomarkers Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Biomarkers Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Biomarkers Revenue by Company (2020-2025) & (US$ Million)
Table 11. Biomarkers Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Biomarkers Players by Revenue (US$ Million) in 2024
Table 13. Global Biomarkers Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Biomarkers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biomarkers as of 2024)
Table 15. Global Biomarkers Companies Headquarters
Table 16. Date of International Companies Enter into Biomarkers Market
Table 17. Global Biomarkers Companies Product & Service
Table 18. Global Biomarkers Mergers & Acquisitions, Expansion Plans
Table 19. Thermo Fisher Scientific Corporation Information
Table 20. Thermo Fisher Scientific Description and Business Overview
Table 21. Thermo Fisher Scientific Biomarkers Product
Table 22. Thermo Fisher Scientific Biomarkers Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Thermo Fisher Scientific Revenue Proportion of Biomarkers by Product in 2024
Table 24. Thermo Fisher Scientific Revenue Proportion of Biomarkers by Application in 2024
Table 25. Thermo Fisher Scientific Revenue Proportion of Biomarkers by Geographic Area in 2024
Table 26. Thermo Fisher Scientific Recent Developments
Table 27. Merck Corporation Information
Table 28. Merck Description and Business Overview
Table 29. Merck Biomarkers Product
Table 30. Merck Biomarkers Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Merck Revenue Proportion of Biomarkers by Product in 2024
Table 32. Merck Revenue Proportion of Biomarkers by Application in 2024
Table 33. Merck Revenue Proportion of Biomarkers by Geographic Area in 2024
Table 34. Merck Recent Developments
Table 35. Bio-Rad Laboratories Corporation Information
Table 36. Bio-Rad Laboratories Description and Business Overview
Table 37. Bio-Rad Laboratories Biomarkers Product
Table 38. Bio-Rad Laboratories Biomarkers Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Bio-Rad Laboratories Revenue Proportion of Biomarkers by Product in 2024
Table 40. Bio-Rad Laboratories Revenue Proportion of Biomarkers by Application in 2024
Table 41. Bio-Rad Laboratories Revenue Proportion of Biomarkers by Geographic Area in 2024
Table 42. Bio-Rad Laboratories Recent Developments
Table 43. QIAGEN Corporation Information
Table 44. QIAGEN Description and Business Overview
Table 45. QIAGEN Biomarkers Product
Table 46. QIAGEN Biomarkers Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. QIAGEN Revenue Proportion of Biomarkers by Product in 2024
Table 48. QIAGEN Revenue Proportion of Biomarkers by Application in 2024
Table 49. QIAGEN Revenue Proportion of Biomarkers by Geographic Area in 2024
Table 50. QIAGEN Recent Developments
Table 51. Roche Corporation Information
Table 52. Roche Description and Business Overview
Table 53. Roche Biomarkers Product
Table 54. Roche Biomarkers Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Roche Revenue Proportion of Biomarkers by Product in 2024
Table 56. Roche Revenue Proportion of Biomarkers by Application in 2024
Table 57. Roche Revenue Proportion of Biomarkers by Geographic Area in 2024
Table 58. Roche Recent Developments
Table 59. Danaher Corporation Corporation Information
Table 60. Danaher Corporation Description and Business Overview
Table 61. Danaher Corporation Biomarkers Product
Table 62. Danaher Corporation Biomarkers Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Danaher Corporation Revenue Proportion of Biomarkers by Product in 2024
Table 64. Danaher Corporation Revenue Proportion of Biomarkers by Application in 2024
Table 65. Danaher Corporation Revenue Proportion of Biomarkers by Geographic Area in 2024
Table 66. Danaher Corporation Recent Developments
Table 67. Siemens Healthcare Corporation Information
Table 68. Siemens Healthcare Description and Business Overview
Table 69. Siemens Healthcare Biomarkers Product
Table 70. Siemens Healthcare Biomarkers Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Siemens Healthcare Revenue Proportion of Biomarkers by Product in 2024
Table 72. Siemens Healthcare Revenue Proportion of Biomarkers by Application in 2024
Table 73. Siemens Healthcare Revenue Proportion of Biomarkers by Geographic Area in 2024
Table 74. Siemens Healthcare Recent Developments
Table 75. Abbott Corporation Information
Table 76. Abbott Description and Business Overview
Table 77. Abbott Biomarkers Product
Table 78. Abbott Biomarkers Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Abbott Revenue Proportion of Biomarkers by Product in 2024
Table 80. Abbott Revenue Proportion of Biomarkers by Application in 2024
Table 81. Abbott Revenue Proportion of Biomarkers by Geographic Area in 2024
Table 82. Abbott Recent Developments
Table 83. Agilent Technologies Corporation Information
Table 84. Agilent Technologies Description and Business Overview
Table 85. Agilent Technologies Biomarkers Product
Table 86. Agilent Technologies Biomarkers Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Agilent Technologies Revenue Proportion of Biomarkers by Product in 2024
Table 88. Agilent Technologies Revenue Proportion of Biomarkers by Application in 2024
Table 89. Agilent Technologies Revenue Proportion of Biomarkers by Geographic Area in 2024
Table 90. Agilent Technologies Recent Developments
Table 91. North America Biomarkers Revenue by Country (2020-2025) & (US$ Million)
Table 92. North America Biomarkers Revenue by Country (2026-2031) & (US$ Million)
Table 93. North America Biomarkers Revenue by Type (2020-2025) & (US$ Million)
Table 94. North America Biomarkers Revenue by Application (2020-2025) & (US$ Million)
Table 95. Asia-Pacific Biomarkers Revenue by Region (2020-2025) & (US$ Million)
Table 96. Asia-Pacific Biomarkers Revenue by Region (2026-2031) & (US$ Million)
Table 97. Asia-Pacific Biomarkers Revenue by Type (2020-2025) & (US$ Million)
Table 98. Asia-Pacific Biomarkers Revenue by Application (2020-2025) & (US$ Million)
Table 99. Europe Biomarkers Revenue by Country (2020-2025) & (US$ Million)
Table 100. Europe Biomarkers Revenue by Country (2026-2031) & (US$ Million)
Table 101. Europe Biomarkers Revenue by Type (2020-2025) & (US$ Million)
Table 102. Europe Biomarkers Revenue by Application (2020-2025) & (US$ Million)
Table 103. Latin America Biomarkers Revenue by Country (2020-2025) & (US$ Million)
Table 104. Latin America Biomarkers Revenue by Country (2026-2031) & (US$ Million)
Table 105. Latin America Biomarkers Revenue by Type (2020-2025) & (US$ Million)
Table 106. Latin America Biomarkers Revenue by Application (2020-2025) & (US$ Million)
Table 107. Middle East and Africa Biomarkers Revenue by Country (2020-2025) & (US$ Million)
Table 108. Middle East and Africa Biomarkers Revenue by Country (2026-2031) & (US$ Million)
Table 109. Middle East and Africa Biomarkers Revenue by Type (2020-2025) & (US$ Million)
Table 110. Middle East and Africa Biomarkers Revenue by Application (2020-2025) & (US$ Million)
Table 111. Biomarkers Key Raw Materials, Industry Status and Trend
Table 112. Biomarkers Key Raw Materials and Upstream Suppliers
Table 113. Biomarkers Clients Status and Trend
Table 114. Biomarkers Typical Clients
Table 115. Biomarkers Distributors
Table 116. Biomarkers Market Trends
Table 117. Biomarkers Market Drivers
Table 118. Biomarkers Market Challenges
Table 119. Biomarkers Market Restraints
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Biomarkers Product Picture
Figure 2. Global Biomarkers Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Biomarkers Revenue Market Share by Type in 2024 & 2031
Figure 4. Sepsis Biomarkers Product Picture
Figure 5. Antibiotic Resistance Biomarkers Product Picture
Figure 6. Traumatic Brain Injury (TBI) Testing Biomarkers Product Picture
Figure 7. Stroke Testing Biomarkers Product Picture
Figure 8. Antibiotic Stewardship Biomarkers Product Picture
Figure 9. Other Product Picture
Figure 10. Global Biomarkers Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 11. Global Biomarkers Revenue Market Share by Application in 2024 & 2031
Figure 12. Diagnostics
Figure 13. Drug Discovery
Figure 14. Personalized Medicine
Figure 15. Other
Figure 16. Biomarkers Report Years Considered
Figure 17. Global Biomarkers Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Biomarkers Market Size (2020-2031) & (US$ Million)
Figure 19. Global Biomarkers Market Size Market Share by Region: 2024 Versus 2031
Figure 20. Global Biomarkers Revenue Market Share by Region (2020-2031)
Figure 21. Global Biomarkers Revenue Market Share Forecast by Type (2020-2031)
Figure 22. Global Biomarkers Revenue Market Share Forecast by Application (2020-2031)
Figure 23. Sepsis Biomarkers of Biomarkers Revenue Market Share by Application, 2024 VS 2031
Figure 24. Antibiotic Resistance Biomarkers of Biomarkers Revenue Market Share by Application, 2024 VS 2031
Figure 25. Traumatic Brain Injury (TBI) Testing Biomarkers of Biomarkers Revenue Market Share by Application, 2024 VS 2031
Figure 26. Stroke Testing Biomarkers of Biomarkers Revenue Market Share by Application, 2024 VS 2031
Figure 27. Antibiotic Stewardship Biomarkers of Biomarkers Revenue Market Share by Application, 2024 VS 2031
Figure 28. Other of Biomarkers Revenue Market Share by Application, 2024 VS 2031
Figure 29. Biomarkers Revenue Share by Company (2024)
Figure 30. Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 31. Sepsis Biomarkers Revenue Proportion by Company in 2024
Figure 32. Antibiotic Resistance Biomarkers Revenue Proportion by Company in 2024
Figure 33. Traumatic Brain Injury (TBI) Testing Biomarkers Revenue Proportion by Company in 2024
Figure 34. Stroke Testing Biomarkers Revenue Proportion by Company in 2024
Figure 35. Antibiotic Stewardship Biomarkers Revenue Proportion by Company in 2024
Figure 36. Other Revenue Proportion by Company in 2024
Figure 37. North America Biomarkers Revenue 2020-2031 (US$ Million)
Figure 38. North America Biomarkers Revenue Market Share by Type (2020-2025)
Figure 39. North America Biomarkers Revenue Market Share by Application (2020-2025)
Figure 40. Asia-Pacific Biomarkers Revenue 2020-2031 (US$ Million)
Figure 41. Asia-Pacific Biomarkers Revenue Market Share by Region (2020-2031)
Figure 42. Asia-Pacific Biomarkers Revenue Market Share by Type (2020-2025)
Figure 43. Asia-Pacific Biomarkers Revenue Market Share by Application (2020-2025)
Figure 44. Europe Biomarkers Revenue Growth Rate 2020-2031 (US$ Million)
Figure 45. Europe Biomarkers Revenue Market Share by Country (2020-2031)
Figure 46. Europe Biomarkers Revenue Market Share by Type (2020-2025)
Figure 47. Europe Biomarkers Revenue Market Share by Application (2020-2025)
Figure 48. Latin America Biomarkers Revenue Growth Rate 2020-2031 (US$ Million)
Figure 49. Latin America Biomarkers Revenue Market Share by Country (2020-2031)
Figure 50. Latin America Biomarkers Revenue Market Share by Type (2020-2025)
Figure 51. Latin America Biomarkers Revenue Market Share by Application (2020-2025)
Figure 52. Middle East and Africa Biomarkers Revenue Growth Rate 2020-2031 (US$ Million)
Figure 53. Middle East and Africa Biomarkers Revenue Market Share by Country (2020-2031)
Figure 54. Middle East and Africa Biomarkers Revenue Market Share by Type (2020-2025)
Figure 55. Middle East and Africa Biomarkers Revenue Market Share by Application (2020-2025)
Figure 56. Biomarkers Supply Chain (Upstream and Downstream Market)
Figure 57. Global Production Market Share of Biomarkers Raw Materials by Region in 2024
Figure 58. Biomarkers Distribution Channels
Figure 59. Global Biomarkers Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 60. Global Biomarkers Percentage 2020-2031: Online Sales VS Offline Sales
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Biomarkers Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Biomarkers Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Biomarkers Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Biomarkers Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Biomarkers Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Biomarkers Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Biomarkers Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Biomarkers Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Biomarkers Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Biomarkers Revenue by Company (2020-2025) & (US$ Million)
Table 11. Biomarkers Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Biomarkers Players by Revenue (US$ Million) in 2024
Table 13. Global Biomarkers Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Biomarkers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biomarkers as of 2024)
Table 15. Global Biomarkers Companies Headquarters
Table 16. Date of International Companies Enter into Biomarkers Market
Table 17. Global Biomarkers Companies Product & Service
Table 18. Global Biomarkers Mergers & Acquisitions, Expansion Plans
Table 19. Thermo Fisher Scientific Corporation Information
Table 20. Thermo Fisher Scientific Description and Business Overview
Table 21. Thermo Fisher Scientific Biomarkers Product
Table 22. Thermo Fisher Scientific Biomarkers Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Thermo Fisher Scientific Revenue Proportion of Biomarkers by Product in 2024
Table 24. Thermo Fisher Scientific Revenue Proportion of Biomarkers by Application in 2024
Table 25. Thermo Fisher Scientific Revenue Proportion of Biomarkers by Geographic Area in 2024
Table 26. Thermo Fisher Scientific Recent Developments
Table 27. Merck Corporation Information
Table 28. Merck Description and Business Overview
Table 29. Merck Biomarkers Product
Table 30. Merck Biomarkers Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Merck Revenue Proportion of Biomarkers by Product in 2024
Table 32. Merck Revenue Proportion of Biomarkers by Application in 2024
Table 33. Merck Revenue Proportion of Biomarkers by Geographic Area in 2024
Table 34. Merck Recent Developments
Table 35. Bio-Rad Laboratories Corporation Information
Table 36. Bio-Rad Laboratories Description and Business Overview
Table 37. Bio-Rad Laboratories Biomarkers Product
Table 38. Bio-Rad Laboratories Biomarkers Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Bio-Rad Laboratories Revenue Proportion of Biomarkers by Product in 2024
Table 40. Bio-Rad Laboratories Revenue Proportion of Biomarkers by Application in 2024
Table 41. Bio-Rad Laboratories Revenue Proportion of Biomarkers by Geographic Area in 2024
Table 42. Bio-Rad Laboratories Recent Developments
Table 43. QIAGEN Corporation Information
Table 44. QIAGEN Description and Business Overview
Table 45. QIAGEN Biomarkers Product
Table 46. QIAGEN Biomarkers Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. QIAGEN Revenue Proportion of Biomarkers by Product in 2024
Table 48. QIAGEN Revenue Proportion of Biomarkers by Application in 2024
Table 49. QIAGEN Revenue Proportion of Biomarkers by Geographic Area in 2024
Table 50. QIAGEN Recent Developments
Table 51. Roche Corporation Information
Table 52. Roche Description and Business Overview
Table 53. Roche Biomarkers Product
Table 54. Roche Biomarkers Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Roche Revenue Proportion of Biomarkers by Product in 2024
Table 56. Roche Revenue Proportion of Biomarkers by Application in 2024
Table 57. Roche Revenue Proportion of Biomarkers by Geographic Area in 2024
Table 58. Roche Recent Developments
Table 59. Danaher Corporation Corporation Information
Table 60. Danaher Corporation Description and Business Overview
Table 61. Danaher Corporation Biomarkers Product
Table 62. Danaher Corporation Biomarkers Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Danaher Corporation Revenue Proportion of Biomarkers by Product in 2024
Table 64. Danaher Corporation Revenue Proportion of Biomarkers by Application in 2024
Table 65. Danaher Corporation Revenue Proportion of Biomarkers by Geographic Area in 2024
Table 66. Danaher Corporation Recent Developments
Table 67. Siemens Healthcare Corporation Information
Table 68. Siemens Healthcare Description and Business Overview
Table 69. Siemens Healthcare Biomarkers Product
Table 70. Siemens Healthcare Biomarkers Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Siemens Healthcare Revenue Proportion of Biomarkers by Product in 2024
Table 72. Siemens Healthcare Revenue Proportion of Biomarkers by Application in 2024
Table 73. Siemens Healthcare Revenue Proportion of Biomarkers by Geographic Area in 2024
Table 74. Siemens Healthcare Recent Developments
Table 75. Abbott Corporation Information
Table 76. Abbott Description and Business Overview
Table 77. Abbott Biomarkers Product
Table 78. Abbott Biomarkers Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Abbott Revenue Proportion of Biomarkers by Product in 2024
Table 80. Abbott Revenue Proportion of Biomarkers by Application in 2024
Table 81. Abbott Revenue Proportion of Biomarkers by Geographic Area in 2024
Table 82. Abbott Recent Developments
Table 83. Agilent Technologies Corporation Information
Table 84. Agilent Technologies Description and Business Overview
Table 85. Agilent Technologies Biomarkers Product
Table 86. Agilent Technologies Biomarkers Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Agilent Technologies Revenue Proportion of Biomarkers by Product in 2024
Table 88. Agilent Technologies Revenue Proportion of Biomarkers by Application in 2024
Table 89. Agilent Technologies Revenue Proportion of Biomarkers by Geographic Area in 2024
Table 90. Agilent Technologies Recent Developments
Table 91. North America Biomarkers Revenue by Country (2020-2025) & (US$ Million)
Table 92. North America Biomarkers Revenue by Country (2026-2031) & (US$ Million)
Table 93. North America Biomarkers Revenue by Type (2020-2025) & (US$ Million)
Table 94. North America Biomarkers Revenue by Application (2020-2025) & (US$ Million)
Table 95. Asia-Pacific Biomarkers Revenue by Region (2020-2025) & (US$ Million)
Table 96. Asia-Pacific Biomarkers Revenue by Region (2026-2031) & (US$ Million)
Table 97. Asia-Pacific Biomarkers Revenue by Type (2020-2025) & (US$ Million)
Table 98. Asia-Pacific Biomarkers Revenue by Application (2020-2025) & (US$ Million)
Table 99. Europe Biomarkers Revenue by Country (2020-2025) & (US$ Million)
Table 100. Europe Biomarkers Revenue by Country (2026-2031) & (US$ Million)
Table 101. Europe Biomarkers Revenue by Type (2020-2025) & (US$ Million)
Table 102. Europe Biomarkers Revenue by Application (2020-2025) & (US$ Million)
Table 103. Latin America Biomarkers Revenue by Country (2020-2025) & (US$ Million)
Table 104. Latin America Biomarkers Revenue by Country (2026-2031) & (US$ Million)
Table 105. Latin America Biomarkers Revenue by Type (2020-2025) & (US$ Million)
Table 106. Latin America Biomarkers Revenue by Application (2020-2025) & (US$ Million)
Table 107. Middle East and Africa Biomarkers Revenue by Country (2020-2025) & (US$ Million)
Table 108. Middle East and Africa Biomarkers Revenue by Country (2026-2031) & (US$ Million)
Table 109. Middle East and Africa Biomarkers Revenue by Type (2020-2025) & (US$ Million)
Table 110. Middle East and Africa Biomarkers Revenue by Application (2020-2025) & (US$ Million)
Table 111. Biomarkers Key Raw Materials, Industry Status and Trend
Table 112. Biomarkers Key Raw Materials and Upstream Suppliers
Table 113. Biomarkers Clients Status and Trend
Table 114. Biomarkers Typical Clients
Table 115. Biomarkers Distributors
Table 116. Biomarkers Market Trends
Table 117. Biomarkers Market Drivers
Table 118. Biomarkers Market Challenges
Table 119. Biomarkers Market Restraints
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Biomarkers Product Picture
Figure 2. Global Biomarkers Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Biomarkers Revenue Market Share by Type in 2024 & 2031
Figure 4. Sepsis Biomarkers Product Picture
Figure 5. Antibiotic Resistance Biomarkers Product Picture
Figure 6. Traumatic Brain Injury (TBI) Testing Biomarkers Product Picture
Figure 7. Stroke Testing Biomarkers Product Picture
Figure 8. Antibiotic Stewardship Biomarkers Product Picture
Figure 9. Other Product Picture
Figure 10. Global Biomarkers Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 11. Global Biomarkers Revenue Market Share by Application in 2024 & 2031
Figure 12. Diagnostics
Figure 13. Drug Discovery
Figure 14. Personalized Medicine
Figure 15. Other
Figure 16. Biomarkers Report Years Considered
Figure 17. Global Biomarkers Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Biomarkers Market Size (2020-2031) & (US$ Million)
Figure 19. Global Biomarkers Market Size Market Share by Region: 2024 Versus 2031
Figure 20. Global Biomarkers Revenue Market Share by Region (2020-2031)
Figure 21. Global Biomarkers Revenue Market Share Forecast by Type (2020-2031)
Figure 22. Global Biomarkers Revenue Market Share Forecast by Application (2020-2031)
Figure 23. Sepsis Biomarkers of Biomarkers Revenue Market Share by Application, 2024 VS 2031
Figure 24. Antibiotic Resistance Biomarkers of Biomarkers Revenue Market Share by Application, 2024 VS 2031
Figure 25. Traumatic Brain Injury (TBI) Testing Biomarkers of Biomarkers Revenue Market Share by Application, 2024 VS 2031
Figure 26. Stroke Testing Biomarkers of Biomarkers Revenue Market Share by Application, 2024 VS 2031
Figure 27. Antibiotic Stewardship Biomarkers of Biomarkers Revenue Market Share by Application, 2024 VS 2031
Figure 28. Other of Biomarkers Revenue Market Share by Application, 2024 VS 2031
Figure 29. Biomarkers Revenue Share by Company (2024)
Figure 30. Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 31. Sepsis Biomarkers Revenue Proportion by Company in 2024
Figure 32. Antibiotic Resistance Biomarkers Revenue Proportion by Company in 2024
Figure 33. Traumatic Brain Injury (TBI) Testing Biomarkers Revenue Proportion by Company in 2024
Figure 34. Stroke Testing Biomarkers Revenue Proportion by Company in 2024
Figure 35. Antibiotic Stewardship Biomarkers Revenue Proportion by Company in 2024
Figure 36. Other Revenue Proportion by Company in 2024
Figure 37. North America Biomarkers Revenue 2020-2031 (US$ Million)
Figure 38. North America Biomarkers Revenue Market Share by Type (2020-2025)
Figure 39. North America Biomarkers Revenue Market Share by Application (2020-2025)
Figure 40. Asia-Pacific Biomarkers Revenue 2020-2031 (US$ Million)
Figure 41. Asia-Pacific Biomarkers Revenue Market Share by Region (2020-2031)
Figure 42. Asia-Pacific Biomarkers Revenue Market Share by Type (2020-2025)
Figure 43. Asia-Pacific Biomarkers Revenue Market Share by Application (2020-2025)
Figure 44. Europe Biomarkers Revenue Growth Rate 2020-2031 (US$ Million)
Figure 45. Europe Biomarkers Revenue Market Share by Country (2020-2031)
Figure 46. Europe Biomarkers Revenue Market Share by Type (2020-2025)
Figure 47. Europe Biomarkers Revenue Market Share by Application (2020-2025)
Figure 48. Latin America Biomarkers Revenue Growth Rate 2020-2031 (US$ Million)
Figure 49. Latin America Biomarkers Revenue Market Share by Country (2020-2031)
Figure 50. Latin America Biomarkers Revenue Market Share by Type (2020-2025)
Figure 51. Latin America Biomarkers Revenue Market Share by Application (2020-2025)
Figure 52. Middle East and Africa Biomarkers Revenue Growth Rate 2020-2031 (US$ Million)
Figure 53. Middle East and Africa Biomarkers Revenue Market Share by Country (2020-2031)
Figure 54. Middle East and Africa Biomarkers Revenue Market Share by Type (2020-2025)
Figure 55. Middle East and Africa Biomarkers Revenue Market Share by Application (2020-2025)
Figure 56. Biomarkers Supply Chain (Upstream and Downstream Market)
Figure 57. Global Production Market Share of Biomarkers Raw Materials by Region in 2024
Figure 58. Biomarkers Distribution Channels
Figure 59. Global Biomarkers Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 60. Global Biomarkers Percentage 2020-2031: Online Sales VS Offline Sales
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232